Loading...
Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
In a mouse model of breast carcinoma, the combination of cyclophosphamide and transforming growth factor β1,2,3 (TGFβ1,2,3)-targeting antibody achieved superior antineoplastic effects. This novel paradigm of synergistic chemoimmunotherapy promises to improve the clinical outcome of cancer patients w...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Landes Bioscience
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063140/ https://ncbi.nlm.nih.gov/pubmed/25050195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28247 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|